We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
As with all licensed medicines, we will continue to monitor its safety closely as it becomes more widely used
Thalia was the Director of the Geospatial Commission, which is an independent Expert Committee within the UK Government’s Department for Science, Innovation and Technology, tasked with advising the government on priorities for improving the UK’s location data, running the public sector’s...
Upper Tribunal Administrative Appeals Chamber decision by Judge Wikeley on 17 October 2025.
Immunocore Limited is recalling the batches listed below as a precautionary measure. The recall is due to a decrease in potency identified during stability testing. All other stability test results remain within specification.
As with all products, the MHRA will keep its safety under close review.
The CMA investigated alleged excessive and unfair pricing with respect to liothyronine tablets under Chapter II CA98.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).